Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
Background Several different formulations of valproic acid derivatives are available in the United States. Although these formulations have different absorption characteristics, they are believed to be interchangeable, with the exception of the extended-release product. Case Report A 31-year-old Afr...
Saved in:
Main Author: | Davis Erica A. K. PharmD, BCPS, BCPP (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials
by: Chen Qi Zhang, et al.
Published: (2022) -
Rifampin-divalproex drug-drug interaction in an adult patient: A case report
by: Christine Doran, PharmD, et al.
Published: (2021) -
The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022) -
Veteran adherence to oral versus injectable AUD medication treatment
by: Hayden Stewart, PharmD, et al.
Published: (2021) -
Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy
by: Kyle Wesselman, PharmD candidate, MA, BS, et al.
Published: (2024)